scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1021777324 |
P356 | DOI | 10.1007/S12011-014-0111-8 |
P698 | PubMed publication ID | 25164034 |
P5875 | ResearchGate publication ID | 265134369 |
P50 | author | Nic E. Savaskan | Q37605290 |
Eduard Yakubov | Q85318839 | ||
P2093 | author name string | Michael Buchfelder | |
Ilker Y Eyüpoglu | |||
P2860 | cites work | Selenium and risk of bladder cancer: a population-based case-control study | Q37093831 |
Selenium supplementation restores innate and humoral immune responses in footrot-affected sheep | Q37373933 | ||
Antioxidant activity of sulfur and selenium: a review of reactive oxygen species scavenging, glutathione peroxidase, and metal-binding antioxidant mechanisms | Q37528192 | ||
Mice lacking selenoprotein P and selenocysteine lyase exhibit severe neurological dysfunction, neurodegeneration, and audiogenic seizures | Q37683377 | ||
Baseline selenium status and effects of selenium and vitamin e supplementation on prostate cancer risk | Q37683660 | ||
Temozolomide: therapeutic limitations in the treatment of adult high-grade gliomas | Q37798254 | ||
Selenium and selenoprotein function in brain disorders | Q38199451 | ||
Selenium reduces mobile phone (900 MHz)-induced oxidative stress, mitochondrial function, and apoptosis in breast cancer cells | Q38981278 | ||
Augmented antitumor effects of combination therapy of cisplatin with ethaselen as a novel thioredoxin reductase inhibitor on human A549 cell in vivo | Q39875482 | ||
Methylseleninic acid enhances taxane drug efficacy against human prostate cancer and down-regulates antiapoptotic proteins Bcl-XL and survivin | Q40012045 | ||
Inhibition of glioma cell line A-172 MMP activity and cell invasion in vitro by a nutrient mixture | Q40082273 | ||
Neuronal and ependymal expression of selenoprotein P in the human brain | Q40179769 | ||
Temozolomide-mediated radiation enhancement in glioblastoma: a report on underlying mechanisms | Q40245213 | ||
Pseudopalisades in glioblastoma are hypoxic, express extracellular matrix proteases, and are formed by an actively migrating cell population | Q40590816 | ||
What is the place of carboplatin in paediatric oncology? | Q40738978 | ||
Nephrotoxicity and hydration management for cisplatin, carboplatin, and ormaplatin | Q40848346 | ||
A histopathological study of nephrotoxicity, hepatoxicity or testicular toxicity: Which one is the first observation as side effect of Cisplatin-induced toxicity in animal model? | Q41861324 | ||
Gene disruption discloses role of selenoprotein P in selenium delivery to target tissues | Q42127289 | ||
Keshan disease, selenium deficiency, and the selenoproteome | Q42217155 | ||
High dietary intake of sodium selenite induces oxidative DNA damage in rat liver | Q42463315 | ||
Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. | Q42528232 | ||
DNA damage-mediated apoptosis induced by selenium compounds. | Q42801439 | ||
Testicular gametogenic and steroidogenic activities in cyclophosphamide treated rat: a correlative study with testicular oxidative stress | Q44098516 | ||
The nutritional prevention of cancer: 400 mcg per day selenium treatment | Q44134098 | ||
Melatonin ameliorates oxidative stress and reproductive toxicity induced by cyclophosphamide in male mice | Q44269473 | ||
Selenium and high dose vitamin E administration protects cisplatin-induced oxidative damage to renal, liver and lens tissues in rats. | Q44748535 | ||
Prophylactic action of melatonin against cyclophosphamide-induced oxidative stress in mice | Q44796364 | ||
Thioredoxin reductase regulates angiogenesis by increasing endothelial cell-derived vascular endothelial growth factor | Q45204941 | ||
Experimental tumor therapy in mice using the cyclophosphamide-activating cytochrome P450 2B1 gene | Q45871076 | ||
Ebselen attenuates cyclophosphamide-induced oxidative stress and DNA damage in mice | Q46230305 | ||
Chemoprotective effect of lipoic acid against cyclophosphamide-induced changes in the rat sperm | Q46737941 | ||
Comparative analysis of selenocysteine machinery and selenoproteome gene expression in mouse brain identifies neurons as key functional sites of selenium in mammals | Q46886702 | ||
Neuroprotection induced by N-acetylcysteine and selenium against traumatic brain injury-induced apoptosis and calcium entry in hippocampus of rat. | Q46892507 | ||
Protective effect of Selenium nanoparticle against cyclophosphamide induced hepatotoxicity and genotoxicity in Swiss albino mice | Q46932549 | ||
Molecular cloning of cDNA encoding a bovine selenoprotein P-like protein containing 12 selenocysteines and a (His-Pro) rich domain insertion, and its regional expression | Q48073251 | ||
Role for glutathione peroxidase-4 in brain development and neuronal apoptosis: specific induction of enzyme expression in reactive astrocytes following brain injury | Q48120010 | ||
Immunocytochemical localization of seleno-glutathione peroxidase in the adult mouse brain | Q48878014 | ||
Toxicity and mutagenicity of selenium compounds in Saccharomyces cerevisiae. | Q53524996 | ||
Selenium modulates oxidative stress-induced cell apoptosis in human myeloid HL-60 cells through regulation of calcium release and caspase-3 and -9 activities. | Q54054717 | ||
Selenium and brain function: a poorly recognized liaison | Q56611276 | ||
Methylseleninic acid enhances paclitaxel efficacy for the treatment of triple-negative breast cancer | Q21134780 | ||
Characterization of mammalian selenoproteomes. | Q27863319 | ||
From selenium to selenoproteins: synthesis, identity, and their role in human health | Q27863358 | ||
Induction of Cell Migration by Matrix Metalloprotease-2 Cleavage of Laminin-5 | Q28242922 | ||
Rational incorporation of selenium into temozolomide elicits superior antitumor activity associated with both apoptotic and autophagic cell death | Q28482143 | ||
Deletion of selenoprotein P alters distribution of selenium in the mouse | Q28512024 | ||
Malignant gliomas in adults | Q29615708 | ||
Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT) | Q29619860 | ||
Results of NCI-sponsored phase I trials with carboplatin | Q33458116 | ||
Early clinical studies with cis-diammine-1,1-cyclobutane dicarboxylate platinum II. | Q33481362 | ||
Selenium metabolism, selenoproteins and mechanisms of cancer prevention: complexities with thioredoxin reductase | Q33723955 | ||
Se-methylselenocysteine sensitizes hypoxic tumor cells to irinotecan by targeting hypoxia-inducible factor 1alpha | Q34047866 | ||
Diversity and functional plasticity of eukaryotic selenoproteins: identification and characterization of the SelJ family | Q34132221 | ||
Designing the selenium and bladder cancer trial (SELEBLAT), a phase lll randomized chemoprevention study with selenium on recurrence of bladder cancer in Belgium | Q34205117 | ||
The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals | Q34370181 | ||
Pathophysiological aspects of cyclophosphamide and ifosfamide induced hemorrhagic cystitis; implication of reactive oxygen and nitrogen species as well as PARP activation | Q34574053 | ||
Chemotherapy-associated renal dysfunction | Q34609452 | ||
Molecular biology of glutathione peroxidase 4: from genomic structure to developmental expression and neural function. | Q34655209 | ||
Plants, selenium and human health | Q35130150 | ||
Role of selenium-containing proteins in T-cell and macrophage function | Q35202342 | ||
Selenium and its relationship to cancer: an update | Q35641512 | ||
Molecular actions of selenium in the brain: neuroprotective mechanisms of an essential trace element. | Q35716547 | ||
Selenium and endocrine systems | Q36062981 | ||
Absence of selenoprotein P but not selenocysteine lyase results in severe neurological dysfunction | Q36074553 | ||
Long isoform mouse selenoprotein P (Sepp1) supplies rat myoblast L8 cells with selenium via endocytosis mediated by heparin binding properties and apolipoprotein E receptor-2 (ApoER2) | Q36217257 | ||
Production of selenoprotein P (Sepp1) by hepatocytes is central to selenium homeostasis | Q36418836 | ||
Using chemopreventive agents to enhance the efficacy of cancer therapy | Q36439479 | ||
Selenium: from cancer prevention to DNA damage | Q36578612 | ||
Cyclophosphamide toxicity. Characterising and avoiding the problem | Q36711562 | ||
Translational regulation of glutathione peroxidase 4 expression through guanine-rich sequence-binding factor 1 is essential for embryonic brain development | Q36802844 | ||
P433 | issue | 3 | |
P304 | page(s) | 246-254 | |
P577 | publication date | 2014-08-28 | |
P1433 | published in | Biological Trace Element Research | Q15716661 |
P1476 | title | Selenium action in neuro-oncology | |
P478 | volume | 161 |
Q38682401 | Biological activity of selenium: Revisited |
Q38935901 | Biological functions of selenium and its potential influence on Parkinson's disease |
Q37060349 | Dietary Selenium Supplementation Modulates Growth of Brain Metastatic Tumors and Changes the Expression of Adhesion Molecules in Brain Microvessels |
Q55321973 | Enhanced glioma-targeting and stability of LGICP peptide coupled with stabilized peptide DA7R. |
Q50794974 | Facile One-Pot Synthesis of Tellurium Nanorods as Antioxidant and Anticancer Agents. |
Q38866548 | Protective Role of Selenium Compounds on the Proliferation, Apoptosis, and Angiogenesis of a Canine Breast Cancer Cell Line. |
Q92811033 | Selenium Anticancer Properties and Impact on Cellular Redox Status |
Search more.